As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Nvidia is expanding physical AI through new partnerships in lab robotics and ...

GERMANTOWN, Md. & VENLO, Netherlands, February 03, 2026--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the first public showcase of QIAsprint Connect at SLAS ...

Biosero, announces the early-access release of new assistive AI capabilities integrated into Green Button Go®, an innovation that allows users to create, review, and troubleshoot automation workflows ...

Drug discovery pipelines are notorious for being costly, slow, and failure-prone, leading to AI and machine learning becoming more commonplace to accelerate progress and improve outcomes. Currently, ...

Two researchers in white lab coats and goggles regard the robotic elements of a lab of the future enabled by artificial intelligence. Exscientia recently opened a laboratory in Oxfordshire, England, ...

René Lacerte, CEO, reported that "During Q2, we continued to build on the strong momentum of Q1 and delivered a meaningful beat on both core revenue and profitability. Our consistent and disciplined ...

Artificial intelligence (AI) in drug discovery is moving beyond the proof-of-concept stage. Advanced machine learning (ML) techniques are powering technologies that slash the time needed to value and ...